Kenyatta National Hospital
Kisumu, Kenya
Location status: Recruiting
NCT Number: NCT05187897
Neonatal mortality (defined as death in the first 28 days of life) remains unacceptably high in sub-Sarahan Africa. The concentrated risk of neonatal illness in the first weeks of life and its potential to rapidly deteriorate means that expanding mothers' access to timely information and support during this period is critical to reducing neonatal mortality. This cluster-randomized control trial aims to integrate a 2 way interactive SMS text messaging intervention into existing digital infrastructure supporting Community Health Volunteer (CHV) workflow in Western Kenya (dCHT) to enable remote communication by mothers with CHVs between home visits.
Interested in participating?
Request Info14 year and older
Female
Interventional
Not applicable
Kisumu, Kenya
Location status: Recruiting
In Kenya, the neonatal mortality rate is 22.6 per 1000 live births, ranking among the countries with the highest number of neonatal deaths (~40,000 per year). Community health volunteers (CHVs) are a large cadre of lay health workers whose role is to promote access to preventative care and treatment in resource-limited settings. In Kenya, CHVs conduct monthly home visits to pregnant and postpartum women to provide education and screen for complications. Several counties in Kenya have adopted a digital community health toolkit (dCHT) that supports CHV workflow by tracking clients, managing tasks, and guiding home visits. Even so, the concentrated risk of neonatal illness in the first weeks of life and its potential to rapidly deteriorate mean that even monthly home visits leave mothers and neonates in need of on-demand support.
Our team developed an interactive SMS text messaging intervention, Mobile WACh Neo (NEO), that connects mothers with healthcare workers remotely in the high-risk period immediately following birth to improve maternal and neonatal health. NEO sends automated, theory-based, actionable daily messages that systematically guide mothers to evaluate neonatal danger signs, and facilitates real-time dialogue with a healthcare worker to triage medical concerns and augment maternal social support.
The overarching goal of this project is to integrate NEO interactive SMS into the existing digital infrastructure supporting CHV workflow in Western Kenya (dCHT) to enable remote communication by mothers with CHVs between home visits. This is a cluster-randomized control trial consisting of 20 facility clusters (10 control, 10 intervention) in Western Kenya.
AIM 1: Employ a human-centered design approach to develop a NEO interactive SMS module in the dCHT, named CHV-NEO.
AIM 2: a) Evaluate CHV-NEO's impact on neonatal mortality, b) clinic visit attendance, and caregiver provision of essential newborn care (cord care, thermal care and initiation of breastfeeding), in a pragmatic cluster-randomized trial.
AIM 3: a) Determine the effect of CHV-NEO on CHV and supervisor workflow, and b) evaluate determinants of CHV-NEO's acceptability, adoption and fidelity of use.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CHV-NEO is a two-way SMS platform that supports communication between mothers and community health volunteers between home visits. The platform engages mothers with SMS communication and brings timely information and support - asking critical questions at crucial times in order to assess the needs and health of newborns and assist in care seeking decisions. The CHV-NEO SMS intervention is integrated into the current digital community health toolkit (dCHT) to support CHV workflow.
Time frame: 28 days postpartum
Death during 1st 28 days of life
Time frame: 2-weeks postpartum
Number of participants with no application of substances or chlorhexidine only to cord
Time frame: 24-hours postpartum
Number of participants giving infant a bath in 1st 24 hours of life
Time frame: 1-hour postpartum
Number of participants initiating breastfeeding in 1st hour of life
Time frame: 6-weeks postpartum
Proportion of illness episodes with danger signs where the infant attended a medical facility
Time frame: 6-weeks postpartum
Number of danger signs or symptoms successfully named
Time frame: 2 years of study implementation
Number of home visits performed by CHVs
Time frame: 2 years of study implementation
Number of clinic referrals logged in dCHT by CHVs
Time frame: 2 years of study implementation
Time on all CHV/supervisor duties
Time frame: 2 years of study implementation
Perception by CHVs that CHV-NEO is agreeable or satisfactory on the Acceptability of Intervention Measure (higher score is more acceptable)
Time frame: 2 years of study implementation
Proportion of client messages replied to by CHV
Time frame: 2 years of study implementation
Number of client SMS responded to by CHV on time per SOP
Contact information is provided by the study sponsor or research team.
University of Washington
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06125860
Birth Weight, Body Weight
Addis Ababa, Ethiopia
View Trial DetailsNCT04598165
Behavior, Behavioral Symptoms
Ahero, Kisumu County, Kenya
View Trial DetailsNCT05369806
Behavior, Behavioral Symptoms
Ahero, Kisumu County, Kenya
View Trial DetailsNCT03213509
Death, Female Urogenital Diseases and Pregnancy Complications
Shivgarh, Uttar Pradesh, India
View Trial Details